Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

In 2022, Dexcom began rolling out in Europe the Dexcom One system, a straightforward continuous glucose monitoring setup that stripped away some of the bells and whistles of its flagship G-series CGMs ...

Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

Dexcom G7 offers new features with a 60% smaller, discreet wearable patch. The Food and Drug Administration (FDA) has cleared the next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System ...

Diabetes management technology company Intuity Medical announced Wednesday that its POGO Automatic Blood Glucose Monitoring System is available in the U.S. The POGO system uses a cartridge with 10 ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...

Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational ...

Clinicians who provide care for persons with diabetes are excited about continuous glucose monitoring (CGM). The technology with CGM is evolving and becoming more reliable and affordable; as it does, ...

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, including weight management support. The device offers real-time glucose tracking ...